RNU6-1183P

Across TCGA pan-cancer cohorts, RNU6-1183P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-1183P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-1183P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1183P expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

KIRC, ACC, and BLCA are the cancer types where RNU6-1183P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.487	0.649	.005	78	view →
ACC	OS	Tertile	II,III,IV	0.168	0.777	<.001	66	view →
BLCA	DFS	Tertile	IV	0.079	0.480	<.001	45	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
TGCT	OS	Tertile	All	0.771	0.968	.009	30	view →
HNSC	OS	Tertile	IV	0.554	0.340	.019	12	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	9	view →
KIRP	OS	Tertile	All	0.265	0.723	.002	9	view →
THCA	OS	Tertile	II,III,IV	0.914	0.984	.032	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-1183P–KIRC (OS)

Open the KIRC breakdown →